Fact CheckerSign in

NCT07105358Recruiting

Vision Improvement Through Behavioral Rehabilitation And Neuroplasticity Training

Visual Plasticity Following Brain Lesions

Source: ClinicalTrials.gov · Last updated 14 Sept 2026

Brief summary (registry, in English)

The VIBRANT (Vision Improvement through Behavioral Rehabilitation And Neuroplasticity Training) study is a prospective, double-blind, crossover design (within-subject) in participants with homonymous hemianopia-a type of visual field loss resulting from damage to the post-chiasmatic visual pathways. It aims to investigate whether transcranial random noise stimulation (tRNS) combined with perceptual learning-based training has potential for improving visual impairments.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
30 (estimated)
First submitted
11 Jul 2025
Start date
17 Jul 2025
Primary completion date
30 Jun 2028
Lead sponsor
Georgetown University
Diseases
Stroke
NCT number
NCT07105358

What you commit to

  • Study type: Interventional
  • Planned participants: 30
  • From 17 Jul 2025 to the primary completion date, 30 Jun 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Severe mental health challenges that could interfere with study results, or current or recent (within the past 6 months) drug or alcohol abuse or addiction as defined by DSM-5.
  • Previous head injury.
  • Present or past (within past 6 months) drug or alcohol abuse or addiction based on DSM-5.

Other illness

  • Severe CNS diseases or disorders unrelated to the focal lesion, which could interfere with study results.
  • Vision loss resulting from ocular disease or disorder.
  • Any CNS diseases or psychiatric disorders (e.g., epilepsy, schizophrenia) that would interfere with study results.

Age

  • Healthy volunteers (age-matched controls):

Who the study is looking for

  • At least 18 years of age.
  • Capable of providing informed consent and complying with study procedures.
  • Unilateral or bilateral focal brain damage causing loss of vision.
  • At least three months post-stroke or traumatic brain injury, or a stable brain tumor within the past year.
  • At least 18 years of age.
  • Capable of providing informed consent and complying with study procedures.

Criteria the registry did not label

  • Stroke, brain tumor, or traumatic brain injury patients

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Georgetown University Medical Center
Coordinator of this site? Confirm its status
Washington D.C.United StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.